Related Experiment Video
Updated: May 2, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
[Aspirin: once or twice a day?]
Pierre Fontana1, Alessandro Casini2, Françoise Boehlen3
1Service d'angiologie et d'hémostase, HUG, 1211 Genève 14. pierre.fontana@hcuge.ch
Daily aspirin dosing may be less effective for patients with increased platelet turnover, like those with diabetes. Twice-daily dosing might offer more consistent platelet inhibition in these individuals, supporting personalized antiplatelet therapy.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Hematology
Context:
- Aspirin is a standard for preventing ischemic events, typically prescribed once daily.
- This regimen is based on a daily platelet renewal rate of 10-15%.
Purpose:
- To review aspirin dosing strategies in specific patient populations.
- To address the controversy surrounding personalized antiplatelet therapy.
Summary:
- Once-daily aspirin may provide insufficient platelet inhibition when platelet turnover is elevated (e.g., in diabetes, essential thrombocytemia).
- Studies suggest increased platelet function recovery between doses with standard regimens.
- Twice-daily aspirin dosing may achieve more homogeneous platelet inhibition in these patients.
Impact:
- Challenges conventional once-daily aspirin dosing recommendations.
- Highlights the need for personalized antiplatelet strategies.
- Informs clinical practice for patients requiring enhanced ischemic event prevention.
Related Concept Videos
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Dosage Regimen: Multiple Oral Dosage
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

